French
Arabic
Jad WAKIM
Chargé (e) d’enseignement
Faculty of Medicine
+961 (1) 421 000 jad.wakim2@usj.edu.lb
Dr Jad Wakim is a Hematologist-Oncologist trained at the University of Texas Southwestern its NCI-designated Comprehensive Cancer Center. He is double American Board Certified in Medical Oncology Hematology.
Dr. Wakim was the Director of Sweetwater Cancer Center in Rock Springs, WY for 5 years, affiliated with the Huntsman Cancer Institute, before moving back to his native Lebanon where he joined Hotel-Dieu de France University Hospital Clemenceau Medical Center Affiliated with John Hopkins International. He is a lecturer at the University of Utah Saint Joseph University Faculty of Medicine.
He has earned numerous awards for clinical achievements presentations, and has published many papers and book chapters
Education
| Degree | University | Country | Year |
|---|---|---|---|
| Doctorat d'exercice - Médecine | |||
| Diplôme de Formation médicales spécialisée - Oncology & Hematologi |
Publications and communications
Genetic markers of chronic lymphocytic leukemia: a retrospective study of 312 patients from a reference center in Lebanon. Future Oncology 2023 Sep19(29):1991-2002.
Perceptions of the COVID-19 vaccine among patients with cancer: a single-institution survey. Future Oncology 2021 Nov 17(31):4071-4079.
Helou S., Helou E., Abou-Khalil V., Wakim J., et al. The effect of the COVID-19 pandemic on physicians’ use perception of telehealth: The case of Lebanon. Int. J. Environ. Res. Public Health 2020, 17, 4866
Chaudary P., Wakim J., Khadim H., Karumbaiah KK., Gajra A. Acquired factor X deficiency in systemic amyloidosis: management of two cases. Haemophilia, 2013 Nov 19(6): e375-6.
Wakim JJ., Levenson BM., Matthews D., Naina H. Management of an unusual case of intravascular large B-cell lymphoma of the penis, prostate, bones with CNS relapse. Journal of Clinical Oncology, 2013 June 1031(17):e288-9.
Wakim JJ., Tirado CA., Dowell J., and Chen W. The first case of Philadelphia-negative acute promyelocytic leukemia following imatinib for chronic myeloid leukemia. Cancer Genetics and Cytogenetics, 2012 March;205(3): p124-127.
Wakim JJ. and Tirado CA (January 2012). Acute promyelocytic leukemia lacking the classic translocation t(15;17). In: Koschmieder, S. and Krug, U. (Editors). Myeloid Leukemia – Clinical Diagnosis and Treatment. Chapter 12, p219-234. Intech.
Wakim JJ., Tirado CA., Chen W., and Collins R. t(8;22)/BCR-FGFR1 myeloproliferative disorder presenting as B-acute lymphoblastic leukemia: report of a case treated with sorafenib and review of the literature. Leukemia Research, 2011 Sep;35(9):e151-3